TR
EN
Long-term 25-hydroxy vitamin D3 level of patients supplied with total thyroidectomy due to nodular goiter.
Abstract
Introduction: One of the most important problems developing in patients who have undergone thyroidectomy
is hypocalcemia. For this reason, the calcium (Ca) level is screened in patients, but it is not routinely screened
for low levels of 25-hydroxy vitamin D3 (25-OH D3), which is found to be associated with many diseases in the
postoperative mid-period, in normocalcemic patients who have undergone thyroidectomy.
Material and method: The study included 60 normocalcemic patients (Group 1) who underwent thyroidectomy
due to nodular goiter and 170 patients (Group 2) who applied with the suspicion of thyroid disease and who
were evaluated as normal and who did not receive Ca and 25-OH D3 supplements (Group 2). Biochemical
hypocalcemia was defined as a corrected Ca level of less than 8.0 mg/dL. 25-OH D3 levels of all patients at the
postoperative 12th month were recorded by scanning their Ca levels and routine laboratory tests.
Results: Measurements were made in 12th month postoperatively. The 25-OH D3 levels of the patients in Group
1 were lower than the 25-OH D3 lev els of the patients in Group 2 (p<0.001). The thyroxine (T4) hormone levels
of the patients in Group 1 were higher than the T4 values of the patients in Group 2 (p=0.002). There was no
statistically significant difference between the Ca levels of the patients in Group 1 and Group 2. (p>0.05). There
was no difference between other measurement parameters.
Conclusion: We think that in patients who underwent thyroidectomy due to nodular goiter, their 25-OH D3
levels should be screened in the postoperative period and replaced if necessary.
is hypocalcemia. For this reason, the calcium (Ca) level is screened in patients, but it is not routinely screened
for low levels of 25-hydroxy vitamin D3 (25-OH D3), which is found to be associated with many diseases in the
postoperative mid-period, in normocalcemic patients who have undergone thyroidectomy.
Material and method: The study included 60 normocalcemic patients (Group 1) who underwent thyroidectomy
due to nodular goiter and 170 patients (Group 2) who applied with the suspicion of thyroid disease and who
were evaluated as normal and who did not receive Ca and 25-OH D3 supplements (Group 2). Biochemical
hypocalcemia was defined as a corrected Ca level of less than 8.0 mg/dL. 25-OH D3 levels of all patients at the
postoperative 12th month were recorded by scanning their Ca levels and routine laboratory tests.
Results: Measurements were made in 12th month postoperatively. The 25-OH D3 levels of the patients in Group
1 were lower than the 25-OH D3 lev els of the patients in Group 2 (p<0.001). The thyroxine (T4) hormone levels
of the patients in Group 1 were higher than the T4 values of the patients in Group 2 (p=0.002). There was no
statistically significant difference between the Ca levels of the patients in Group 1 and Group 2. (p>0.05). There
was no difference between other measurement parameters.
Conclusion: We think that in patients who underwent thyroidectomy due to nodular goiter, their 25-OH D3
levels should be screened in the postoperative period and replaced if necessary.
Keywords
References
- 1. Dean, D.S. and H. Gharib, Epidemiology of thyroid nodules. Best practice & research Clinical endocrinology & metabolism, 2008. 22(6): p. 901-911.
- 2. Paschou, S.Α., A. Vryonidou, and D.G. Goulis, Thyroid nodules: Α guide to assessment, treatment and follow-up. Maturitas, 2017. 96: p. 1-9.
- 3. Biello, A., E.C. Kinberg, and E.D. Wirtz, Thyroidectomy. StatPearls [Internet], 2020.
Details
Primary Language
English
Subjects
Surgery
Journal Section
Research Article
Publication Date
April 1, 2022
Submission Date
September 9, 2021
Acceptance Date
November 1, 2021
Published in Issue
Year 2022 Volume: 15 Number: 2
APA
Bolat, H., & Kaçmaz, M. (2022). Long-term 25-hydroxy vitamin D3 level of patients supplied with total thyroidectomy due to nodular goiter. Pamukkale Medical Journal, 15(2), 277-284. https://doi.org/10.31362/patd.993108
AMA
1.Bolat H, Kaçmaz M. Long-term 25-hydroxy vitamin D3 level of patients supplied with total thyroidectomy due to nodular goiter. Pam Med J. 2022;15(2):277-284. doi:10.31362/patd.993108
Chicago
Bolat, Hacı, and Mustafa Kaçmaz. 2022. “Long-Term 25-Hydroxy Vitamin D3 Level of Patients Supplied With Total Thyroidectomy Due to Nodular Goiter”. Pamukkale Medical Journal 15 (2): 277-84. https://doi.org/10.31362/patd.993108.
EndNote
Bolat H, Kaçmaz M (April 1, 2022) Long-term 25-hydroxy vitamin D3 level of patients supplied with total thyroidectomy due to nodular goiter. Pamukkale Medical Journal 15 2 277–284.
IEEE
[1]H. Bolat and M. Kaçmaz, “Long-term 25-hydroxy vitamin D3 level of patients supplied with total thyroidectomy due to nodular goiter”., Pam Med J, vol. 15, no. 2, pp. 277–284, Apr. 2022, doi: 10.31362/patd.993108.
ISNAD
Bolat, Hacı - Kaçmaz, Mustafa. “Long-Term 25-Hydroxy Vitamin D3 Level of Patients Supplied With Total Thyroidectomy Due to Nodular Goiter”. Pamukkale Medical Journal 15/2 (April 1, 2022): 277-284. https://doi.org/10.31362/patd.993108.
JAMA
1.Bolat H, Kaçmaz M. Long-term 25-hydroxy vitamin D3 level of patients supplied with total thyroidectomy due to nodular goiter. Pam Med J. 2022;15:277–284.
MLA
Bolat, Hacı, and Mustafa Kaçmaz. “Long-Term 25-Hydroxy Vitamin D3 Level of Patients Supplied With Total Thyroidectomy Due to Nodular Goiter”. Pamukkale Medical Journal, vol. 15, no. 2, Apr. 2022, pp. 277-84, doi:10.31362/patd.993108.
Vancouver
1.Hacı Bolat, Mustafa Kaçmaz. Long-term 25-hydroxy vitamin D3 level of patients supplied with total thyroidectomy due to nodular goiter. Pam Med J. 2022 Apr. 1;15(2):277-84. doi:10.31362/patd.993108
